Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» R&D
R&D
7 big pharma companies sign on to Parkinson's development group
BioPharma Dive
Wed, 02/24/16 - 11:49 am
R&D
AbbVie
AstraZeneca
Biogen
Eli Lilly
Merck
Pfizer
UCB Pharma
Parkinson's Disease
Sanofi cuts research staffers in Boston as reorganization looms: report
Fierce Biotech
Tue, 02/23/16 - 05:55 pm
R&D
Sanofi
layoffs
Novartis, Broad researchers find hope in potential gene target for intractable cancers
BioPharma Dive
Tue, 02/23/16 - 09:51 am
Novartis
cancer
R&D
Gilead Launches New Grants Program to Support HIV Cure
Yahoo
Mon, 02/22/16 - 10:05 am
Gilead Sciences
HIV
grants
R&D
Merck CEO Kenneth Frazier talks about pricing, R&D—and why big pharmaceutical companies aren’t admired like they once were
Forbes
Mon, 02/22/16 - 09:43 am
Merck
Pharma CEOs
Kenneth Frazier
drug pricing
R&D
GlaxoSmithKline Partners With VBI Vaccines, SciVac To Eliminate Cold Chain
Yahoo
Wed, 02/17/16 - 10:39 am
GSK
VBI Vaccines
SciVac
R&D
AbbVie, Maker of World's No. 1 Drug, Bets Synthetic Biology Startup Can Raise the Bar
Forbes
Wed, 02/10/16 - 09:39 am
AbbVie
Synlogic
R&D
inflammatory bowel disease
Teva Shareholders Shrug Off Latest Collaborative Research Agreement
Yahoo/Benzinga
Wed, 02/3/16 - 08:43 am
Teva Pharmaceutical
shareholders
R&D
AbCellera
monoclonal antibodies
How Much Is Teva Spending on Research and Development?
Yahoo/Market Realist
Fri, 01/29/16 - 08:26 pm
Teva Pharmaceutical
R&D
Small Deals to Continue in 2016 for Johnson & Johnson
Motley Fool
Fri, 01/29/16 - 08:25 pm
JNJ
M&A
R&D
Merck bets up to $515M on an epigenetic project for cancer and blood disease
Fierce Biotech
Thu, 01/28/16 - 09:11 pm
Merck
epigenetics
CRUK
blood disease
cancer
R&D
Novartis reshuffles its $9B R&D operation to save $1B a year
Fierce Biotech
Wed, 01/27/16 - 04:16 pm
Novartis
R&D
reorganization
Pfizer partners with nonprofit Calibr to develop heart failure drugs
BioPharma Dive
Fri, 01/15/16 - 02:37 pm
Pfizer
Calibr
R&D
heart failure
Pfizer CEO: Our CAR-T development method could give us a leg up over Kite, Juno, Novartis
BioPharma Dive
Thu, 01/14/16 - 08:54 pm
Pfizer
Pharma CEOs
Ian Read
R&D
CAR-T
Novartis
Juno Therapeutics
Kite Pharma
Post-restructuring, Biogen's top execs are back in the R&D talent hunt
Fierce Biotech
Thu, 01/14/16 - 08:52 pm
Biogen
R&D
Takeda teams with enGene for gastrointestinal R&D
Fierce Biotech
Wed, 01/13/16 - 10:32 am
Takeda
enGene
R&D
gastrointestinal
Pfizer Expands R&D Equity Investment Strategy to Access Early-Stage Scientific Innovations
Yahoo
Sun, 01/10/16 - 03:17 pm
Pfizer
R&D
Mylan, Momenta Team Up To Develop Biosimilar Drugs
Investors.com
Sat, 01/9/16 - 10:32 am
Mylan Labs
Momenta
biosimilars
R&D
Is the Hatch-Waxman System Broken?
Pharm Exec
Thu, 01/7/16 - 12:59 pm
Hatch Waxman Act
generics
R&D
Chapel Hill drug developer Cempra looks to raise $200M
Bizjournals.com
Wed, 01/6/16 - 07:58 pm
Cempra
R&D
Pages
« first
‹ previous
…
51
52
53
54
55
56
57
58
59
…
next ›
last »